These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4571486)

  • 1. [Are hypoglycemic sulfonamides dangerous?].
    Aubertin MJ
    Bord Med; 1972 Nov; 5(17):2287-90. PubMed ID: 4571486
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral therapy in diabetes].
    Kirkeby K
    Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1620-1. PubMed ID: 4588817
    [No Abstract]   [Full Text] [Related]  

  • 3. [Are oral antidiabetics ineffective-or even dangerous? The "University Group Diabetes Program" (UGDP) as basis for a controversial discussion on the therapy of diabetes in the aged].
    Teuscher A
    Schweiz Med Wochenschr; 1972 Jun; 102(24):848-55. PubMed ID: 5033623
    [No Abstract]   [Full Text] [Related]  

  • 4. The UGDP--tolbutamide and mortality.
    Knowles HC
    Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
    [No Abstract]   [Full Text] [Related]  

  • 5. [Should the prescription of oral antidiabetic drugs be more limited? Results from controlled clinical trials].
    Folling I
    Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1604-6. PubMed ID: 4769481
    [No Abstract]   [Full Text] [Related]  

  • 6. The FDA and hypoglycemic drugs.
    Davidson JK
    JAMA; 1975 May; 232(8):853-5. PubMed ID: 1091764
    [No Abstract]   [Full Text] [Related]  

  • 7. Comments on the UGDP study.
    Schöffling K
    Horm Metab Res; 1974; Suppl 4():188-91. PubMed ID: 4608018
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term experience with sulfonylureas and placebo.
    Singer DL; Hurwitz D
    N Engl J Med; 1967 Aug; 277(9):450-6. PubMed ID: 5340346
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tolbutamide controversy; falling into the pit sobbing].
    Touber JL
    Ned Tijdschr Geneeskd; 1975 Nov; 119(46):1821-8. PubMed ID: 1107858
    [No Abstract]   [Full Text] [Related]  

  • 10. [University Group Diabetes Program. The UGDP investigation remains clinically unacceptable].
    Aarseth S
    Tidsskr Nor Laegeforen; 1976 Aug; 96(22):1148. PubMed ID: 951693
    [No Abstract]   [Full Text] [Related]  

  • 11. A note on tolbutamide and diabetes.
    Med Lett Drugs Ther; 1970 Jul; 12(14):60. PubMed ID: 4935987
    [No Abstract]   [Full Text] [Related]  

  • 12. Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents.
    JAMA; 1975 Feb; 231(6):583-608. PubMed ID: 1089822
    [No Abstract]   [Full Text] [Related]  

  • 13. Misunderstanding or error? The UGDP report after four years.
    Marigo S; Adezati L; Burnetti P; Pozza G; Robba L; Urbinati G
    Acta Diabetol Lat; 1974; 11(5):357-422. PubMed ID: 4156992
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorials: Statistical problems in clinical trials: the UGDP study revisited.
    Schor SS
    Am J Med; 1973 Dec; 55(6):727-32. PubMed ID: 4584989
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolbutamide (Orinase) and diabetes.
    Med Lett Drugs Ther; 1970 Nov; 12(24):97-8. PubMed ID: 5514167
    [No Abstract]   [Full Text] [Related]  

  • 16. Controlled clinical trials and the tolbutamide controversy.
    Lavietes PH
    Conn Med; 1971 Apr; 35(4):271-2. PubMed ID: 4927818
    [No Abstract]   [Full Text] [Related]  

  • 17. [A comparative study of older and newer types of peroral antidiabetics].
    Dobesová L; Sieberová R
    Vnitr Lek; 1967 Apr; 13(4):344-7. PubMed ID: 4860055
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolbutamide and diabetes.
    Can Med Assoc J; 1971 Jun; 104(12):1067. PubMed ID: 5580750
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy.
    Gray RH
    Med J Aust; 1973 Mar; 1(12):594-6. PubMed ID: 4573383
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of tolbutamide on the diabetic fatty liver.
    Beringer A; Hrabal I; Irsigler K; Thaler H
    Ger Med Mon; 1968 Dec; 13(12):595-8. PubMed ID: 4898499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.